Laurie Myers sold $841 of CING
EVP and COO at Cingulate Inc.. 202 shares at an average of $4.17, traded Aug 15, 2024, filed Aug 19, 2024.
Score components
- +20RoleCOO
- 0Trade size$841 at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -61.4%, 3m -68.6%, 6m -64.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-24-033196, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 15, 2024 | SOpen-market sale Common Stock | -202 | $4.17 | $841 | 0 | Aug 19, 2024 |
Related signals
Other insiders at Cingulate Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 62Notable | Cingulate Inc. | Thomas Jeffrey Hargroves director | $490k 97,276 shares | first purchase | |
| 40Moderate | Cingulate Inc. | Matthew Brams EVP and Chief Medical Officer | $9,808 1,946 shares | +72% | |
| 47Moderate | Cingulate Inc. | Jennifer L. Callahan SVP and CFO | $25k 4,864 shares | +2494% | |
| 56Moderate | Cingulate Inc. | Shane J. Schaffer Chief Executive Officer | $34k 6,809 shares | +202% | |
| 43Moderate | Cingulate Inc. | Peter J. Werth director | $98k 19,455 shares | +20% | |
| 30Weak | CINGbuy Cingulate Inc. | Jennifer L. Callahan SVP and CFO | $1,491 55 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.